JEFFREY PRATER: Open Payments
NPI 1659401461 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,352 in 88 payments from 12 companies in 2025. Trend: 2023 $762 · 2024 $828 · 2025 $1,352
Food & beverage: $1,352
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $382 |
| Alkermes, Inc. | 17 | $182 |
| Otsuka America Pharmaceutical, Inc. | 10 | $178 |
| Vanda Pharmaceuticals Inc. | 14 | $164 |
| ABBVIE INC. | 10 | $152 |
| Neurocrine BioSciences, Inc. | 5 | $77 |
| Lundbeck LLC | 4 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: CAPLYTA, REXULTI, HETLIOZ, VRAYLAR, ARISTADA, INGREZZA, LYBALVI, SPRAVATO.
Industry payments across KY — which companies pay providers there.
